9 October 2025NewsCareersMarisa Woutersen

Teva in-house counsel jumps to private practice

The hire brings experience managing global trademark, copyright, and domain portfolios, as well as prior in-house roles at Teva and Johnson & Johnson.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Novartis tops Big Pharma in global trademark portfolios

15 May 2025 Trademark activity surged across major markets in 2024 | Swiss pharma ranks among top foreign portfolios in US, UK and EU | Mainland China is largest filer worldwide despite dip in applications | Several major life sciences companies held strong US trademark portfolios.

Europe

Teva loses TM appeal over ‘French version’ of slogan

9 July 2020 Drug company Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the EU General Court ruled in favour of the European Union IP Office (EUIPO) yesterday, July 8.

More features

Gilead blocks HIV drug generics for more than 10 years

Bridging Brunel and AI: Why CIPA sees ‘a golden opportunity’

Brazil’s patent shake-up: How pharma is handling a new reality

Eli Lilly strikes AI drug discovery deal with US biotech

Why AI drug discovery has an IP problem and what can be done

Blank Rome adds more patent attorneys in ‘strategic expansion’

Simmons & Simmons patent litigator jumps ship

ITC probes on the rise, but gender parity lags behind

Teva in-house counsel jumps to private practice

More on this story

Editor's picks

Editor's picks

More features